Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
LONDON, Sept 9 (Reuters) - AstraZeneca has paused global trials of its experimental coronavirus vaccine after an unexplained illness in a participant, denting the British drugmaker's shares on Wednesday as the move was seen as dimming prospects f...
Read more
(Sharecast News) - AstraZeneca paused the phase three clinical trial of the Covid-19 vaccine candidate that it was developing in conjunction with the University of Oxford, in response to a possible unexplained illness in one of the participants.
Read more(Adds background, detail on trial subject)Sept 8 (Reuters) - AstraZeneca Plc has put a hold on the late-stage trial of its highly-anticipated COVID-19 vaccine candidate after a suspected serious adverse reaction in a study participant, health news...
Read more(Adds AstraZeneca comment, Moderna comment, byline)By Deena BeasleySept 8 (Reuters) - AstraZeneca Plc on Tuesday said it has paused a late-stage trial of one of the leading COVID-19 vaccine candidates after an unexplained illness in a study partic...
Read more(Adds quote attributed by Stat to AstraZeneca, details)Sept 8 (Reuters) - AstraZeneca Plc has paused a late-stage trial of one of the leading COVID-19 vaccine candidates after a suspected serious adverse reaction in a study participant, health new...
Read more* Companies pledge to uphold integrity of scientific process* Debate about speed of development has become heated* Mass testing with control groups are needed - statement (Adds Inovio CEO comment)By Ludwig Burger, Patricia Weiss and Caroline CopleyF...
Read more* Companies pledge to uphold integrity of scientific process* Debate about speed of development has become heated* Mass testing with control groups are needed - statement (Adds industry comment, background)By Ludwig Burger, Patricia Weiss and Caroli...
Read more(Sharecast News) - Hargreaves Lansdown: Berenberg upgrades to buy with a target price of 1,915.0p.
Read more(Sharecast News) - The bosses of nine of the world's largest pharmaceutical companies pledged to put science and safety first in the race to find a vaccine for Covid-19.
Read moreBy Ludwig Burger and Patricia WeissFRANKFURT, Sept 8 (Reuters) - Nine leading U.S. and European vaccine developers pledged on Tuesday to uphold the scientific standards that their experimental immunisations will be held against, amid a hurried glo...
Read more
UK BROKER RATINGS SUMMARY: Barclays Cuts GVC And Raises Flutter
Read moreWelcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) i...
Read more(Sharecast News) - Big Pharma paced gains in London at the start of the week, led by shares in Dechra Pharmaceuticals after the veterinary drugs maker hiked its dividend payout following what it described as an "encouraging" start to its new financial year.
Read moreWelcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) i...
Read moreWelcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) i...
Read more
Last checked at